Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |Streptavidin（SA） Hot |Claudin 18.2 |Cadherin-17 
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > IL-3 R alpha

IL-3 R alpha

Brief Information

Name:Interleukin-3 receptor subunit alpha
Target Synonym:IL3RY,IL-3RA,CD123 Antigen,IL3RX,IL-3R Subunit Alpha,IL3R,IL-3 Receptor Subunit Alpha,IL-3 Receptor Alpha SP2 Isoform,Interleukin 3 Receptor Subunit Alpha,IL3RAY,IL-3R-Alpha,CD123,HIL-3Ra,IL3RA,Interleukin 3 Receptor, Alpha (Low Affinity),Interleukin-3 Receptor Subunit Alpha,Interleukin-3 Receptor alpha Subunit
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:36
Lastest Research Phase:Approved

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
ILA-HA2H8 Human APC-Labeled Human IL-3 R alpha / CD123 Protein, His Tag (Site-specific conjugation)
ILA-HA2H8-structure
ILA-H8214 Human Biotinylated Human IL-3 R alpha / CD123 Protein, Avitag™ (MALS verified)
ILA-H8214-structure
ILA-H8214-sds
ILA-HP2H8 Human PE-Labeled Human IL-3 R alpha / CD123 Protein, His Tag (Site-specific conjugation)
ILA-HP2H8-structure
ILA-H82F3 Human Biotinylated Human IL-3 R alpha / CD123 Protein, Fc,Avitag™ (MALS verified)
ILA-H82F3-structure
ILA-H82F3-sds
ILA-HF253 Human FITC-Labeled Human IL-3 R alpha / CD123 Protein, Fc Tag
ILA-HF253-structure
ILA-HF253-sds
ILA-H5252 Human Human IL-3 R alpha / CD123 Protein, Fc Tag (MALS & SPR verified)
ILA-H5252-structure
ILA-H5252-sds
ILA-C52H3 Canine Canine IL-3 R alpha / CD123 Protein, His Tag
ILA-C52H3-structure
ILA-C52H3-sds
ILA-H82H5 Human Biotinylated Human IL-3 R alpha / CD123 Protein, His,Avitag™ (MALS verified)
ILA-H82H5-structure
ILA-H82H5-sds
ILA-HF2H9 Human FITC-Labeled Human IL-3 R alpha / CD123 Protein, His Tag
ILA-HF2H9-structure
ILA-HF2H9-sds
ILA-M52H4 Mouse Mouse IL-3 R alpha / CD123 Protein, His Tag (SPR verified)
ILA-M52H4-structure
ILA-M52H4-sds
ILA-C52H6 Cynomolgus Cynomolgus IL-3 R alpha / CD123 Protein, His Tag (SPR verified)
ILA-C52H6-structure
ILA-C52H6-sds
ILA-H5255 Human Human IL-3 R alpha / CD123 Protein, Llama IgG2b Fc Tag, low endotoxin
ILA-H5255-structure
ILA-H5255-sds
ILA-H52H6 Human Human IL-3 R alpha / CD123 Protein, His Tag (MALS & SPR verified)
ILA-H52H6-structure
ILA-H52H6-sds
ACRO Quality

Part of Bioactivity data

ILA-HA2H8-Cell-based assay
IL-3 R alpha FACS

5e5 of anti-IL-3 R alpha CAR-293 cells were stained with 100 μL of 1:25 dilution (4 μL stock solution in 100 μL FACS buffer) of APC-Labeled Human IL-3 R alpha Protein, His Tag (Cat. No. ILA-HA2H8) and negative control protein respectively. APC signal was used to evaluate the binding activity (QC tested).

Protocol
ILA-HP2H8-Cell-based assay
FACS assay shows that recombinant Biotinylated FACS

5e5 of anti-IL-3 R alpha CAR-293 cells were stained with 100 μL of 1:25 dilution (4 μL stock solution in 100 μL FACS buffer) of PE-Labeled Human IL-3 R alpha, His Tag (Cat. No. ILA-HP2H8) and negative control protein respectively. PE signal was used to evaluate the binding activity (QC tested).

Protocol
ILA-H5252-SPR
IL-3 R alpha SPR

Anti-IL-3 R alpha Antibody, Human IgG1 immobilized on CM5 Chip can bind Human IL-3 R alpha, Fc Tag (Cat. No. ILA-H5252) with an affinity constant of 50.3 nM as determined in a SPR assay (Biacore T200) (QC tested).

Protocol
ILA-M52H4-SPR
Human_FcRn_Heterodimer_Protein_SPR

Immobilized Mouse IL-3 R alpha, His Tag (Cat. No. ILA-M52H4) on CM5 Chip can bind Mouse IL-3 Protein, His Tag (Cat. No. IL3-M52H8) with an affinity constant of 0.929 μM as determined in a SPR assay (Biacore T200) (QC tested).

Protocol

Customer Reviews

Synonym Name

IL3R,IL3RA,IL-3Ra,IL-3R-alpha,IL3RAY,IL3RX,IL3RY,CD123 antigen,CD123,hIL3Ra,hIL-3Ra,MGC34174,IL-3 R alpha

Background

Interleukin 3 receptor alpha (low affinity) (IL3RA), also known as CD123 (Cluster of Differentiation 123) is a 70-kD glycoprotein member of the hematopoietin receptor superfamily. This protein associates with a beta subunit common to the receptors for IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) to form a high-affinity receptor for IL-3. The interleukin-3 receptor α chain (CD123) has been identified as a potential immunotherapeutic target because it is overexpressed in AML compared with normal hematopoietic stem cells.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Tagraxofusp DTIL-3; DT388 IL3; SL-401 Approved Texas A&M University Development Foundation Elzonris EU Lymphoma; Blastic Plasmacytoid Dendritic Cell Neoplasm Stemline Therapeutics Inc 2018-12-21 Leukemia; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Multiple Myeloma; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Lymphoma Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Anti-CD123 CAR T-cell therapy (Southwest Hospital) Phase 2 Clinical Southwest Hospital Chongqing Leukemia, Myeloid Details
Anti-CD123 CAR T-cell therapy (Nanjing Legend Biotech) Phase 1 Clinical Leukemia, Myeloid, Acute Details
Anti-CD123 CAR T cell therapy (Shanghai GeneChem) Phase 1 Clinical Shanghai Genechem Co Ltd Leukemia, Myeloid, Acute Details
SQZ-622(Novartis Pharma) SQZ-622 Phase 1 Clinical Novartis Pharma Ag Leukemia, Myeloid, Acute Details
Anti-CD123 CAR T-cell therapy (University of Pennsylvania/Novartis) JEZ-567 Phase 1 Clinical Novartis Pharma Ag, University Of Pennsylvania Leukemia, Myeloid, Acute Details
UniCAR02-T UniCAR02-T Phase 1 Clinical Cellex Patient Treatment Gmbh Kidney Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
CD123 CAR-T cells (Hebei Senlang Biotechnology) Hebei Senlang Biological Technology Co Ltd Details
CD123 CAR-T cell therapy(Chongqing Precision Biotechnology) Chongqing Precision Biotechnology Co Ltd Details
CD123/CLL1 CAR-T Cell Therapy (Fujian Medical University) Fujian Medical University Details
IM-23 (Beijing Immunochina Medical Science and Technology) IM-23; IM-23 CAR-T Beijing Immunochina Medical Science & Technology Co Ltd Details
SGN-CD123A SGN-CD123A Seattle Genetics Inc Details
CSL-360 IL-3Rα; CSL-360 Csl Ltd Details
UniCAR-T-CD-123 UniCAR-T-CD123 Phase 1 Clinical Gemoab Monoclonals Gmbh Leukemia, Myeloid, Acute Details
Talacotuzumab CSL-362; JNJ-473; CSL-362-AML; JNJ-56022473; IL-13 MAb-CSL Phase 2 Clinical Csl Ltd Myelodysplastic Syndromes; Leukemia, Myeloid, Acute Details
JNJ-63709178 JNJ-9178; CNTO-9958; JNJ-63709178 Phase 1 Clinical Janssen Global Services Llc, Genmab A/S Leukemia, Myeloid, Acute Details
UCART-123 UCART-123 Phase 1 Clinical Cellectis Sa Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute Details
CD19-CD123 cCAR T-cells Therapy(iCell Gene Therapeutics) ICG140 iCell Gene Therapeutics LLC Details
MB-102 (Mustang Bio) MB-102 Phase 3 Clinical Mustang Bio Inc, City Of Hope National Medical Center Neoplasm, Residual; Acute Kidney Injury; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Biphenotypic, Acute Details
ACLX-002 ACLX-002 Phase 1 Clinical Arcellx Inc Myelodysplastic Syndromes; Leukemia, Myeloid, Acute Details
Anti-CD123 CAR-T cell therapy (Wuhan Union Hospital) Phase 1 Clinical Wuhan Bio-Raid Biotechnology, Wuhan Union Hospital Leukemia, Myeloid, Acute Details
Pivekimab sunirine IMGN-632 Phase 2 Clinical Immunogen Inc Myeloproliferative Disorders; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute Details
Vibecotamab XmAb-14045 Phase 1 Clinical Xencor Inc Leukemia, Myeloid; Blastic Plasmacytoid Dendritic Cell Neoplasm; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute Details
Allogenic CD123-CAR-NK Cells therapy(JD Biotech) JD023 Phase 1 Clinical Beijing JD Biotech Co Ltd, Chinese Academy Of Military Medical Sciences Leukemia, Myeloid, Acute Details
GR-1901 GR1901; GR-1901 Phase 1 Clinical Chongqing Zhixiang Jintai Biopharmaceutical Co Ltd, Zhixiang (Shanghai) Pharmaceutical Technology Co Ltd Leukemia, Myeloid, Acute Details
APVO436 APVO-436 Phase 1 Clinical Aptevo Myeloproliferative Disorders; Leukemia, Myeloid, Acute Details
MGD-024 MGD-024 Phase 1 Clinical Macrogenics Inc Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Hairy Cell; Neoplasms; Hodgkin Disease; Myelodysplastic Syndromes; Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, B-Cell; Leukemia, Myeloid, Acute Details
Flotetuzumab S-80880; MGD-006; RES-234 Phase 2 Clinical Macrogenics Inc Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hematologic Neoplasms; Leukemia, Hairy Cell; Hodgkin Disease; Mastocytosis, Systemic; Blastic Plasmacytoid Dendritic Cell Neoplasm; Neoplasms, Plasma Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Leukemia, Biphenotypic, Acute Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap